Hasil Pencarian  ::  Simpan CSV :: Kembali

"Tujuan : Penelitian ini bertujuan membandingkan kadar serum petanda biologik: Interleukin-6, Tumor Necrosis Factor-alpha, Matrix-Metalloproteinase-2 Dan Vascular Endothelial Growth Factor pada endometriosis stadium I-II dan stadium III-IV.Metode : Empat puluh pasien endometriosis yang terdiagnosis berdasarkan laparoskopi diambil sampel serum sebelum operasi untuk pemeriksaan petanda biologik. Pemeriksaan petanda biologik dilakukan di akhir penelitian dengan cara ELISA. Rerata dari kadar serum dilakukan uji T tidak berpasangan. Variabel yang terdapat perbedaan bermakna dilakukan pemeriksaan ROC dan ditentukan titik potong optimal.Hasil : Rerata kadar serum petanda biologik: IL-6, TNF-a, MMP-2 dan VEGF pada subjek dengan stadium endometriosis I-II dan III-IV adalah [1,39 vs 1,33] pg/ml (p>0,05); [1,5 ±0,47 vs 1,49±0,29] pg/ml (p>0,05); [152,04 ± 27,32 vs 140,98 ± 28,08] ng/ml (p>0,05) dan [238,78 vs 426,57] pg/ml (p<0,05). Perbedaan rerata VEGF memiliki nilai AUC 74,5%. Titik potong optimal VEGF ≥ 323,95 pg/ml dengan sensitivitas 71,4% dan spesifisitas 69,2%.Kesimpulan : Kadar serum IL-6, TNF-a dan MMP-2 tidak berbeda bermakna pada perempuan endometriosis stadium I-II dan stadium III-IV. Hanya kadar VEGF yang memiliki perbedaan rerata yang bermakna.

---

Purpose : The focus of this study is to compare serum biomarkers of : interleukin-6, tumor necrosis factor-alpha, matrix-metalloproteinase-2 and vascular endothelial growth factor in endometriosis stage I-II and stage III-IV.

Method : Forty endometriosis patient was diagnosed by laparoscopy. Serum sample was taken before the surgery. The serum biomarkers were analyzed with ELISA method at the end of research. Mean of serum biomarkers were tested with unpaired T test. Variable that had significant mean different was thorough ROC measurement and determined the optimal cut of point.

Result : Mean serum biomarkers level of IL-6, TNF-a, MMP-2 and VEGF of endometriosis stage I-II and stage III-IV were [1,39 vs 1,33] pg/ml (p>0,05); [1,5 ±0,47 vs 1,49±0,29] pg/ml (p>0,05); [152,04 ± 27,32 vs 140,98 ± 28,08] ng/ml (p>0,05) and [238,78 vs 426,57] pg/ml (p<0,05). Mean different of VEGF have AUC 74,5%. Optimal cut of point for VEGF ≥ 323,95 pg/ml with sensitivity 71,4% and spesificity 69,2%.

Conclusion : Mean serum level of IL-6, TNF-a and MMP-2 are not different between endometriosis stage I-II and stage III-IV. Only VEGF has significant mean different."

"Latar Belakang: Preeklamsia merupakan penyebab utama morbiditas dan mortalitas ibu dan bayi di seluruh dunia. Gejala preeklamsia disebabkan oleh disfungsi endotel maternal. Eritrosit maternal dapat berperan menyebabkan disfungsi endotel maternal melalui gangguan keseimbangan nitric oxide. Stres oksidatif dan trace elements pada eritrosit dicurigai berperan menyebabkan gangguan produksi nitric oxide. Stres oksidatif eritrosit juga dapat mempengaruhi morfologi eritrosit. Tujuan: Penelitian ini membandingkan aktifitas antioksidan superoxide dismutase eritrosit, kadar trace elements eritrosit dan indeks eritrosit pada kehamilan normal dan preeklamsia. Metode: Penelitian ini merupakan studi potong lintang dengan jumlah sampel 20 pasien preeklamsia dan 20 pasien hamil normal yang melakukan kunjungan pada RS Cipto Mangunkusumo, RSUD Kab. Tangerang dan RSUD Koja. Pemeriksaan antioksidan superoxide dismutase eritrosit dengan metode ELISA dan pemeriksaan trace elements eritrosit dengan metode ICP-MS. Data disajikan dalam tabel dan dianalisis dengan uji parametrik yakni uji-t tidak berpasangan bila sebaran normal atau uji Mann-Whitney U bila sebaran tidak normal. Penelitian ini sudah lolos kaji etik dan mendapatkan persetujuan pelaksanaan dari Komite Etik Penelitian Kesehatan FKUI-RSCM.Hasil: Didapatkan kadar eritrosit preeklamsia dibandingkan kontrol adalah (4,39 ± 0,55 vs 3,84 ± 0,44 juta/ml) (p=0,001), MCV (83,01 ± 8,48 vs 88,53 ± 5,6 fL) (p=0,020), MCH (26,9 ± 3,6 vs 29,6 ± 5,7 pg) (p=0,009) dan MCHC (32,4 ± 1,7 vs 33,4 ± 1,03 %) (p=0,023). Tidak terdapat perbedaan bermakna RDW-CV eritrosit preeklamsia dibandingan kontrol 14,3 (12,5-23,7) vs 14,1 (12-16,2) (p=0,448). Kadar aktifitas SOD eritrosit kelompok preeklamsia dibandingkan kelompok kontrol adalah 35,74 ± 7,97 vs 28,9 ± 6,28 U/ml (p=0,005); Aktifitas SOD/Hb eritrosit kelompok preeklamsia dibandingkan kelompok kontrol adalah 310,8 ± 83,4 vs 257,88 ± 63,1 U/g Hb (p=0,029). Untuk trace elements preeklamsia dibandingkan kontrol adalah : Ferrum (67 (23-82) vs 75 (24-92)) fg/RBC (p=0,033); Cobalt (0,15 (0,05-0,61) vs 0,08(0,02-0,34)) ag/RBC (p=0,027); Selenium (18,5 ± 4,6 vs 21,7 ± 2,8) ag/RBC (p=0,014); Cadmium (0,10 (0,02-0,22) vs 0,33 (0,01-0.14)) (p=0,006) dan Timbal (9,37 ± 4,67 vs 5,6 ± 2,06) ag/RBC (p=0,003). Trace elements eritrosit mangan, nikel, cuprum, seng, arsenik, merkuri dan thalium tidak terdapat perbedaan antara kehamilan preeklamsia dan kontrol.

---

Background : Preeclampsia is a major cause of maternal and infant morbidity and mortality worldwide. Symptoms of preeclampsia are caused by maternal endothelial dysfunction. Maternal erythrocytes can play a role in causing maternal endothelial dysfunction through impaired nitric oxide balance. Oxidative stress and micro-minerals in erythrocytes are suspected to play a role in causing impaired nitric oxide production. Oxidative stress of erythrocytes can also affect the morphology of erythrocytes. Objective : This study compared the anti-oxidant activity of erythrocyte superoxide dismutase, erythrocyte micro mineral content and erythrocyte index in normal pregnancy and preeclampsia. Methods: This study is a cross-sectional study with a sample of 20 patients with preeclampsia and 20 pregnant patients without preeclampsia who visited Cipto Mangunkusumo Hospital, Kab. Tangerang and hospitals. Koja. Examination of erythrocyte superoxide dismutase antioxidant by ELISA method and micro erythrocyte mineral examination by ICP-MS method. The data are presented in tables and analyzed by parametric test, unpaired t-test if the distribution is normal or the Mann-Whitney U test if the distribution is not normal. This research has passed the ethical review and received implementation approval from the Health Research Ethics Committee of the FKUI-RSCM.

Results: The preeclampsia erythrocyte levels compared to controls were (4.39 ± 0.55 vs 3.84 ± 0.44 million/ml) (p=0.001), MCV (83.01 ± 8.48 vs. 88.53 ± 5 .6 fL) (p=0.020), MCH (26.9 ± 3.6 vs 29.6 ± 5.7 pg) (p=0.009) and MCHC (32.4 ± 1.7 vs 33 ,4 ± 1.03%) (p=0.023). There was no significant difference in RDW-CV of preeclampsia erythrocytes compared to controls 14.3 (12.5-23.7) vs. 14.1 (12-16.2) (p=0.448). SOD activity levels of erythrocytes in the preeclampsia group compared to the control group were 35.74 ± 7.97 vs. 28.9 ± 6.28 U/ml (p=0.005);The erythrocyte SOD/Hb activity of the preeclampsia group compared to the control group was 310.8 ± 83.4 vs. 257.88 ± 63.1U/g Hb (p=0.029). For preeclampsia trace minerals compared to controls were: Ferrum (67 (23-82) vs 75 (24-92)) fg/RBC (p=0.033); Cobalt (0.15 (0.05-0.61) vs. 0.08(0.02-0.34)) ag/RBC (p=0.027); Selenium (18.5 ± 4.6 vs. 21.7 ± 2.8) ag/RBC (p=0.014); Cadmium (0.10 (0.02-0.22) vs. 0.33 (0.01-0.14)) (p=0.006) and Lead (9.37 ± 4.67 vs 5.6 ± 2.06) ag/RBC (p=0.003). The trace elements erythrocyte: manganese, nickel, cuprum, seng, arsenic, mercury and thallium showed no significant difference between the preeclampsia and control groups."